Beacon Pointe Advisors, LLC
Position in UTHR — UNITED THERAPEUTICS Corp
CIK 1744317
NEWPORT BEACH, CA
Position in UTHR
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$1,433,232
+$360,308 QoQ
Shares Held
2,417
+9.8% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2025
3 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Common Shares in UTHR Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Beacon Pointe Advisors, LLC holds $6,694,336 across 7 Drug Manufacturers - Specialty & Generic names. UTHR ranks #2 (21.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
29,753 | $3,517,102 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
This page
|
2,417 | $1,433,232 | |
| 3 | TAK |
Takeda Pharmaceutical Co Ltd
|
32,930 | $609,863 | |
| 4 | HLN |
Haleon plc
|
48,499 | $485,474 | |
| 5 | VTRS |
Viatris Inc
|
27,557 | $372,295 | |
| 6 | AQST |
Aquestive Therapeutics, Inc.
|
60,500 | $251,075 | |
| 7 | BTAI |
BioXcel Therapeutics, Inc.
|
18,877 | $25,295 |
All Filings in UTHR
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,433,232 | 2,417 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $1,072,924 | 2,202 | Shares | Sole | 2026-02-18 | |
| 2025-09-30 | $921,842 | 2,199 | Shares | Sole | 2025-11-14 | |
| No filing history on record for this holder in this stock. | ||||||